How AI is Changing the Game in Battling Alzheimer’s
On September 21, World Alzheimer’s Day is celebrated, showcasing the potential of artificial intelligence in addressing this challenge. AlphaFold, a system capable of predicting protein structures, provides scientists with unprecedented tools to understand and treat the disease.
### Alzheimer’s and Misfolded Proteins
Alzheimer’s impacts over 55 million individuals globally, associated with the build-up of amyloid plaques and neurofibrillary tangles in the brain. The misfolding of proteins is a crucial factor in this progression.
### AlphaFold: A Game-Changing Innovation
AlphaFold, trained using a database of over 100,000 known structures, has the ability to forecast protein folding. Its rapid advancement has transformed research and offered open access to a database that is widely utilized by scientists worldwide.
### Applications in Alzheimer’s Research
AlphaFold proves to be a valuable asset in the study of early-onset Alzheimer’s, facilitating in-depth analysis of specific proteins, identification of weaknesses, and the development of targeted medications. This technology allows for personalized treatments tailored to the molecular profile of each patient, potentially addressing the underlying cause of the disease.
